On behalf of the organizing committee we extend an invitation to clinicians and researchers to join us for the 3rd Thomas Ashworth CTC Symposium to be held at the Australian Technology Park, Sydney, on Wednesday 21 September, 2016.
The scientific program will be clinically relevant and cover cutting edge translational research that will feature both national and international leaders in circulating tumour cell biology and clinical application of liquid biopsy. This year’s theme will focus on next generation sequencing (NGS), its clinical use in liquid biopsy for enhancing personalized oncology, and advances in CTC biology and metastasis.
The Sydney Cancer Conference (SCC) follows on the next day (22-23rd September), for which delegates may wish to extend their stay to include this conference. Separate SCC registration applies.
9.00am to 5.30pm (post symposium cocktail reception 5.30 to 6.30pm).
Contact: Kevin Spring (firstname.lastname@example.org)
Register for the event here
Please note: Events publicised on this website align to the goals and objectives of the NSW Cancer Plan, are evidence-based, not-for profit and are conducted by:
- Professional colleges
- Cancer councils
- State-based, national and international cancer control organisations and agencies.
- Cancer or health services
- Government organisations
- Academic institutions.
The Cancer Institute NSW will consider events that meet this criteria on a case-by-case basis, and will not support activities or groups that do not comply with strict evidence-based principles.